![](/img/cover-not-exists.png)
Subcutaneous Immunoglobulin Replacement Therapy with Hizentra® is Safe and Effective in Children Less Than 5 Years of Age
N. C. Patel, J. L. Gallagher, H. D. Ochs, T. Prescott Atkinson, J. Wahlstrom, M. Dorsey, F. A. Bonilla, J. Heimall, L. Kobrynski, D. Morris, E. HaddadVolume:
35
Language:
english
Journal:
Journal of Clinical Immunology
DOI:
10.1007/s10875-015-0190-0
Date:
August, 2015
File:
PDF, 440 KB
english, 2015